ATP6AP2 and heart failure: Another study showed that PRR blockade (HRP, 0.3 mg/kg) attenuated fibrosis and hypertrophy by decreasing ERK1/2 activation and TGF-β expression in mice, ameliorating heart failure caused by chronic kidney disease, with no effect on autophagy (88).